Skip to content

Evaluation of Biomarkers for the Assessment of Disease Activity of Eosinophilic Esophagitis (EoE) in Children

Evaluation of Biomarkers for the Assessment of Disease Activity of Eosinophilic Esophagitis (EoE) in Children - Pediatic EOE Biomarkers

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
DRKS
Registry ID
DRKS00014688
Enrollment
100
Registered
2018-07-12
Start date
2018-09-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K20 K21 T78.1

Interventions

Group 1: Therapy branch 1: Targeted allergen Elimination (after allergological testing) + abstention of cow's milk Group 2: Therapy branch 2: Empiric elimination of the 6 most frequent food allergens

Sponsors

Abteilung für Gastroenterologie und HepatologieKinderklinik Erlangen
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: Pediatric patients including 18 years of age with clinical or laboratorial suspicion of eosinophilic esophagitis

Exclusion criteria

Exclusion criteria: - Other causes for esophageal eosinophilia like chronic inflammatory bowel disease or celiac diesase - Esophageal candidosis or infection with Herpes simplex - Present esophageal gastritis or esophageal Enteritis - Ongoing Treatment with immunosuppressive or immunomodulating substances

Design outcomes

Primary

MeasureTime frame
- Identification ot the most effective treatment branch as assessed by histological criteria for disease remission - Identification of biomarkers and their applicability in childhood to reduce the frequency of gastroscopies for follow up

Secondary

MeasureTime frame
- Identification of tolerance mechanisms to predict the optimal time for reintroduction ot the eliminated food allergen - Applicability of allergological skin tests (sensitivity, specificity, positive and negative predictive value) in childhood EoE (Eosinophilic Esophagitis) - Evaluation whether a susccessful tratment of EoE has an iompact on improving pulmonary obstruction (bronchial asthma) in affected children

Countries

Germany, Switzerland

Contacts

Public ContactAndré Hörning

Abteilung für Gastroenterologie und HepatologieKinderklinik Erlangen

andre.hoerning@uk-erlangen.de09131 85 33118

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026